329 related articles for article (PubMed ID: 19135984)
1. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
[TBL] [Abstract][Full Text] [Related]
2. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
3. Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer.
Dong W; Tu S; Xie J; Sun P; Wu Y; Wang L
Biochem Biophys Res Commun; 2009 Sep; 387(1):132-8. PubMed ID: 19576178
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
[TBL] [Abstract][Full Text] [Related]
5. Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.
Chen X; Cao X; Dong W; Xia M; Luo S; Fan Q; Xie J
Biochem Biophys Res Commun; 2010 Jan; 391(1):1070-4. PubMed ID: 20004178
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
8. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer.
Kim M; Jang HR; Haam K; Kang TW; Kim JH; Kim SY; Noh SM; Song KS; Cho JS; Jeong HY; Kim JC; Yoo HS; Kim YS
Carcinogenesis; 2010 Sep; 31(9):1685-93. PubMed ID: 20627872
[TBL] [Abstract][Full Text] [Related]
9. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
[TBL] [Abstract][Full Text] [Related]
10. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.
Ye Q; Shen Y; Wang X; Yang J; Miao F; Shen C; Zhang J
Tissue Antigens; 2010 Jan; 75(1):30-9. PubMed ID: 19883394
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
15. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
16. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma.
Guo X; Liu W; Pan Y; Ni P; Ji J; Guo L; Zhang J; Wu J; Jiang J; Chen X; Cai Q; Li J; Zhang J; Gu Q; Liu B; Zhu Z; Yu Y
Oncogene; 2010 Jul; 29(27):3908-20. PubMed ID: 20440264
[TBL] [Abstract][Full Text] [Related]
17. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
[TBL] [Abstract][Full Text] [Related]
18. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
[TBL] [Abstract][Full Text] [Related]
19. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.
Shao L; Cui Y; Li H; Liu Y; Zhao H; Wang Y; Zhang Y; Ng KM; Han W; Ma D; Tao Q
Clin Cancer Res; 2007 Oct; 13(19):5756-62. PubMed ID: 17908965
[TBL] [Abstract][Full Text] [Related]
20. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
